I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Development of a nonhuman primate challenge model to evalua..:
Richard Graveline
;
Morad Haida
;
Carolyne Dumont
...
http://dx.doi.org/10.1080/19420862.2021.1979447. , 2022
Link:
https://doi.org/10.1080/19420862.2021.1979447
RT Journal T1
Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ccf957700da242dda01d81adae2e2cd2&Exemplar=1&LAN=DE A1 Richard Graveline A1 Morad Haida A1 Carolyne Dumont A1 Dominic Poulin A1 Florence Poitout-Belissent A1 Rana Samadfam A1 Sven Kronenberg A1 Franziska Regenass-Lechner A1 Rodney Prell A1 Marie-Soleil Piche PB Taylor & Francis Group YR 2022 K1 cd8 t cell function K1 adenovirus K1 nonhuman primate K1 siv antigen challenge K1 checkpoint inhibitors K1 Therapeutics. Pharmacology K1 RM1-950 K1 Immunologic diseases. Allergy K1 RC581-607 JF http://dx.doi.org/10.1080/19420862.2021.1979447 LK http://dx.doi.org/https://doi.org/10.1080/19420862.2021.1979447 DO https://doi.org/10.1080/19420862.2021.1979447 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)